When to treat hypercholesterolaemia
- PMID: 37925276
- DOI: 10.1016/j.medcli.2023.09.001
When to treat hypercholesterolaemia
Comment on
-
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.Lancet. 2015 Apr 11;385(9976):1397-405. doi: 10.1016/S0140-6736(14)61368-4. Epub 2015 Jan 9. Lancet. 2015. PMID: 25579834
Similar articles
-
Targeting hypercholesterolaemia: challenges and opportunities.Eur Heart J. 2023 Jul 1;44(25):2263-2266. doi: 10.1093/eurheartj/ehad415. Eur Heart J. 2023. PMID: 37392136 No abstract available.
-
ANGPTL3 inhibition for hypercholesterolaemia.Nat Rev Cardiol. 2021 Feb;18(2):72. doi: 10.1038/s41569-020-00483-3. Nat Rev Cardiol. 2021. PMID: 33235372 No abstract available.
-
INCLISIRAN - A breakthrough revolution in the treatment of hypercholesterolaemia.J Pak Med Assoc. 2023 Jan;73(1):209. doi: 10.47391/JPMA.6629. J Pak Med Assoc. 2023. PMID: 36842047 No abstract available.
-
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.Drugs. 1978 Jun;15(6):409-28. doi: 10.2165/00003495-197815060-00001. Drugs. 1978. PMID: 350557 Review. No abstract available.
-
Hypercholesterolaemia in aged patients. To treat or not to treat?Drugs Aging. 1991 Nov-Dec;1(6):427-30. doi: 10.2165/00002512-199101060-00002. Drugs Aging. 1991. PMID: 1794029 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical